文献速递重症综合管理与镇静镇痛心脑血管急症

卒中危重患者气管切开时机与结局:系统评价与Meta分析及Meta回归

Tracheostomy timing and outcome in critically ill patients with stroke: a meta-analysis and meta-regression.
PubMed 文献 · Crit Care · 2023-04-01
一句话结论在超过1.7万例卒中危重患者中,气管切开时机与死亡率、神经功能结局或ICU/住院时间均无关。

该系统评价与Meta分析检索5个数据库至2022年11月25日,纳入13项研究共17346例卒中(脑出血83%、缺血性卒中12%、蛛网膜下腔出血5%)并接受气管切开(时机已知)的ICU患者。平均气管切开时间9.7天,总死亡率15.7%,mRS 0-3占五分之一(中位随访180天)。以气管切开时间为连续变量的Meta回归显示与死亡率无统计学显著关联(β=-0.3,95%CI -2.3至1.74,p=0.8);早期(<5天)与晚期(>10天)气管切开死亡率无显著差异(7.8% vs 16.4%,p=0.7)。气管切开时机与神经功能结局、ICU住院时间及住院时间均无关。

要点

  • 卒中机械通气患者中,气管切开时机(连续变量)与全因死亡率无统计学显著关联(β=-0.3,95%CI -2.3至1.74,p=0.8)。
  • 按SETPOINT2方案定义早期(机械通气至气管切开<5天)与晚期(>10天),死亡率无显著差异(早期7.8% vs 晚期16.4%,p=0.7)。
  • 气管切开时机与良好神经功能结局(mRS 0-3)、ICU住院时间及住院时间均无显著关联。
  • 纳入患者平均气管切开时间9.7天,总死亡率15.7%,mRS 0-3占五分之一(中位随访180天)。
  • 平均机械通气约12天,ICU住院时间16天,住院时间28天。

适用人群与场景

  • ICU收治的卒中患者(急性缺血性卒中AIS或脑出血ICH),住院期间接受气管切开且时机已知,每项研究气管切开患者>20例。
  • 主要报告蛛网膜下腔出血(SAH)的研究被排除。

诊断标准与关键阈值

  • 早期气管切开定义为机械通气开始至气管切开<5天,晚期定义为>10天(依据SETPOINT2方案)。

研究设计与关键结果

  • 研究类型:系统评价与Meta分析(含Meta回归),检索5个数据库至2022年11月25日,遵循PRISMA报告规范;纳入13项研究共17346例患者,平均年龄59.8岁,女性44%。
  • 卒中类型构成:ICH 83%、AIS 12%、SAH 5%(占已知卒中类型)。平均气管切开时间9.7天。
  • 主要结局:校正随访后的总全因死亡率为15.7%;以气管切开时间为连续变量的Meta回归显示与死亡率无统计学显著关联(β=-0.3,95%CI -2.3至1.74,p=0.8)。
  • 早期与晚期气管切开比较:死亡率无显著差异(早期7.8% vs 晚期16.4%,p=0.7)。
  • 次要结局:良好神经功能结局(mRS 0-3)占五分之一(中位随访180天);气管切开时机与良好神经功能结局、ICU住院时间及住院时间均无显著关联;平均机械通气约12天,ICU住院时间16天,住院时间28天。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析(含Meta回归),方案注册于PROSPERO(CRD42022351732,注册日期2022年8月17日)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于ICU收治的卒中(AIS或ICH)机械通气患者,气管切开时机(早期<5天 vs 晚期>10天)与死亡率、神经功能结局、ICU住院时间及住院时间均无显著关联。
  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Stroke patients requiring mechanical ventilation often have a poor prognosis. The optimal timing of tracheostomy and its impact on mortality in stroke patients remains uncertain. We performed a systematic review and meta-analysis of tracheostomy timing and its association with reported all-cause overall mortality. Secondary outcomes were the effect of tracheostomy timing on neurological outcome (modified Rankin Scale, mRS), hospital length of stay (LOS), and intensive care unit (ICU) LOS.

METHODS: We searched 5 databases for entries related to acute stroke and tracheostomy from inception to 25 November 2022. We adhered to PRISMA guidance for reporting systematic reviews and meta-analyses. Selected studies included (1) ICU-admitted patients who had stroke (either acute ischaemic stroke, AIS or intracerebral haemorrhage, ICH) and received a tracheostomy (with known timing) during their stay and (2) > 20 tracheotomised. Studies primarily reporting sub-arachnoid haemorrhage (SAH) were excluded. Where this was not possible, adjusted meta-analysis and meta-regression with study-level moderators were performed. Tracheostomy timing was analysed continuously and categorically, where early (< 5 days from initiation of mechanical ventilation to tracheostomy) and late (> 10 days) timing was defined per the protocol of SETPOINT2, the largest and most recent randomised controlled trial on tracheostomy timing in stroke patients.

RESULTS: Thirteen studies involving 17,346 patients (mean age = 59.8 years, female 44%) met the inclusion criteria. ICH, AIS, and SAH comprised 83%, 12%, and 5% of known strokes, respectively. The mean time to tracheostomy was 9.7 days. Overall reported all-cause mortality (adjusted for follow-up) was 15.7%. One in five patients had good neurological outcome (mRS 0-3; median follow-up duration was 180 days). Overall, patients were ventilated for approximately 12 days and had an ICU LOS of 16 days and a hospital LOS of 28 days. A meta-regression analysis using tracheostomy time as a continuous variable showed no statistically significant association between tracheostomy timing and mortality (β = - 0.3, 95% CI = - 2.3 to 1.74, p = 0.8). Early tracheostomy conferred no mortality benefit when compared to late tracheostomy (7.8% vs. 16.4%, p = 0.7). Tracheostomy timing was not associated with secondary outcomes (good neurological outcome, ICU LOS and hospital LOS).

CONCLUSIONS: In this meta-analysis of over 17,000 critically ill stroke patients, the timing of tracheostomy was not associated with mortality, neurological outcomes, or ICU/hospital LOS.

TRIAL REGISTRATION: PROSPERO-CRD42022351732 registered on 17th of August 2022.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Premraj L, Camarda C, White N, et al. Tracheostomy timing and outcome in critically ill patients with stroke: a meta-analysis and meta-regression. Crit Care. 2023. PMID: 37005666. doi:10.1186/s13054-023-04417-6

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。